Cargando…

A Multianalyte Assay Panel With Cell‐Bound Complement Activation Products Predicts Transition of Probable Lupus to American College of Rheumatology–Classified Lupus

OBJECTIVE: To evaluate the usefulness of biomarkers to predict the evolution of patients suspected of systemic lupus erythematosus (SLE), designated as probable SLE (pSLE), into classifiable SLE according to the American College of Rheumatology (ACR) classification criteria. METHODS: Patients suspec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ramsey‐Goldman, Rosalind, Alexander, Roberta Vezza, Conklin, John, Arriens, Cristina, Narain, Sonali, Massarotti, Elena M., Wallace, Daniel J., Collins, Christopher E., Saxena, Amit, Putterman, Chaim, Brady, Kelley, Kalunian, Kenneth C., Weinstein, Arthur
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7882535/ https://www.ncbi.nlm.nih.gov/pubmed/33538130 http://dx.doi.org/10.1002/acr2.11219

Ejemplares similares

Complement Activation in Patients With Probable Systemic Lupus Erythematosus and Ability to Predict Progression to American College of Rheumatology–Classified Systemic Lupus Erythematosus
por: Ramsey‐Goldman, Rosalind, et al.
Publicado: (2019)

Cell-bound complement activation products associate with lupus severity in SLE
por: Arriens, Cristina, et al.
Publicado: (2020)

Reduction in erythrocyte-bound complement activation products and titres of anti-C1q antibodies associate with clinical improvement in systemic lupus erythematosus
por: Buyon, Jill, et al.
Publicado: (2016)

A multianalyte assay panel with cell-bound complement activation products demonstrates clinical utility in systemic lupus erythematosus
por: Alexander, Roberta Vezza, et al.
Publicado: (2021)

Cell-bound complement activation products in systemic lupus erythematosus: comparison with anti-double-stranded DNA and standard complement measurements
por: Putterman, Chaim, et al.
Publicado: (2014)

Erythrocyte-bound C4d in combination with complement and autoantibody status for the monitoring of SLE
por: Merrill, Joan T, et al.
Publicado: (2018)

Gender Differences in the Pathogenesis and Outcome of Lupus and of Lupus Nephritis
por: Schwartzman-Morris, Julie, et al.
Publicado: (2012)

Randomised prospective trial to assess the clinical utility of multianalyte assay panel with complement activation products for the diagnosis of SLE
por: Wallace, Daniel J, et al.
Publicado: (2019)

The Avise Lupus Test and Cell-bound Complement Activation Products Aid the Diagnosis of Systemic Lupus Erythematosus
por: Mossell, James, et al.
Publicado: (2016)

Systemic Lupus Erythematosus
por: Putterman, Chaim, et al.
Publicado: (2012)

The role of anti-α-actinin antibodies in the pathogenesis and monitoring of lupus nephritis
por: Youinou, Pierre, et al.
Publicado: (2009)

The MRL/lpr Mouse Strain as a Model for Neuropsychiatric Systemic Lupus Erythematosus
por: Gulinello, Maria, et al.
Publicado: (2011)

B cells, BAFF/zTNF4, TACI, and systemic lupus erythematosus
por: Dörner, Thomas, et al.
Publicado: (2001)

Neuropsychiatric Lupus, the Blood Brain Barrier, and the TWEAK/Fn14 Pathway
por: Stock, Ariel D., et al.
Publicado: (2013)

Single-cell RNA sequencing for the study of lupus nephritis
por: Der, Evan, et al.
Publicado: (2019)

CXCL13 Neutralization Attenuates Neuropsychiatric Manifestations in Lupus-Prone Mice
por: Huang, Michelle W., et al.
Publicado: (2021)

Cell-bound complement activation products in SLE
por: Ramsey-Goldman, Rosalind, et al.
Publicado: (2017)

Metabolic Disturbances Associated with Systemic Lupus Erythematosus
por: Wu, Tianfu, et al.
Publicado: (2012)

A Distinct T Follicular Helper Cell Subset Infiltrates the Brain in Murine Neuropsychiatric Lupus
por: Jain, Shweta, et al.
Publicado: (2018)

Choroid Plexus–Infiltrating T Cells as Drivers of Murine Neuropsychiatric Lupus
por: Moore, Erica, et al.
Publicado: (2022)

Creatinine Fluctuation in Patients With Lupus Nephritis: Considerations for Clinical Trial Endpoints
por: Almaani, Salem, et al.
Publicado: (2020)

The T Cell Receptor Repertoire in Neuropsychiatric Systemic Lupus Erythematosus
por: Moore, Erica, et al.
Publicado: (2020)

Increased Education is Associated with Decreased Compliance in an Urban Multi-Ethnic Lupus Cohort
por: Gross, Rachel, et al.
Publicado: (2014)

TWEAKing the Hippocampus: The Effects of TWEAK on the Genomic Fabric of the Hippocampus in a Neuropsychiatric Lupus Mouse Model
por: Iacobas, Dumitru A., et al.
Publicado: (2021)

Remodeling of Neurotransmission, Chemokine, and PI3K-AKT Signaling Genomic Fabrics in Neuropsychiatric Systemic Lupus Erythematosus
por: Iacobas, Dumitru, et al.
Publicado: (2021)

Classifying Lupus Nephritis: An Ongoing Story
por: Kiremitci, Saba, et al.
Publicado: (2014)

Dialogue: what can we learn about the relationship between systemic lupus erythematosus and haematological malignancies from linking disease registries?
por: Ramsey-Goldman, Rosalind, et al.
Publicado: (2014)

Elucidating the role of TNF-like weak inducer of apoptosis in the pathogenesis of cutaneous lupus
por: Doerner, Jessica, et al.
Publicado: (2014)

Neuropsychiatric systemic lupus erythematosus persists despite attenuation of systemic disease in MRL/lpr mice
por: Stock, Ariel D., et al.
Publicado: (2015)

Urine VCAM-1 as a marker of renal pathology activity index in lupus nephritis
por: Singh, Sandeep, et al.
Publicado: (2012)

Importance of collaboration of dermatology and rheumatology to advance the field for lupus and dermatomyositis
por: Werth, Victoria P., et al.
Publicado: (2021)

4336 Renal Tubular Complement C9 Deposition is Associated with Renal Tubular Damage and Fibrosis in Lupus Nephritis
por: Wang, Shudan, et al.
Publicado: (2020)

Immune Response to Enterococcus gallinarum in Lupus Patients Is Associated With a Subset of Lupus-Associated Autoantibodies
por: Bagavant, Harini, et al.
Publicado: (2021)

Population-based prevalence and incidence estimates of primary discoid lupus erythematosus from the Manhattan Lupus Surveillance Program
por: Izmirly, Peter, et al.
Publicado: (2019)

Addressing Lupus Health Disparities: The MONARCAS Community and Academic Collaborative Program
por: Mancera-Cuevas, Karen, et al.
Publicado: (2018)

Insulin-Like Growth Factor Binding Protein-4 as a Marker of Chronic Lupus Nephritis
por: Wu, Tianfu, et al.
Publicado: (2016)

Erythrocyte complement receptor 1 (ECR1) and erythrocyte-bound C4d (EC4d) in the prediction of poor pregnancy outcomes in systemic lupus erythematosus (SLE)
por: Conklin, John, et al.
Publicado: (2022)

Neuropsychiatric Systemic Lupus Erythematosus Is Dependent on Sphingosine-1-Phosphate Signaling
por: Mike, Elise V., et al.
Publicado: (2018)

B cell and/or autoantibody deficiency do not prevent neuropsychiatric disease in murine systemic lupus erythematosus
por: Wen, Jing, et al.
Publicado: (2016)

Global excellence in rheumatology in Latin America: The case of systemic lupus erythematosus
por: Ugarte-Gil, Manuel F., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3dortruka4e13esjiglvbqntgn